A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma

KÜÇÜKAY, FAHRETTİN; Badem, Serife; Karan, Adnan; Ozdemir, Mustafa; Okten, Riza; Ozbulbul, Nilgun; KÜÇÜKAY, MURAT; Unlu, Ipek; Bostanci, Erdal; Akdogan, Meral

doi:10.1016/j.jvir.2015.07.017

A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma

Copy For Citation

KÜÇÜKAY F., Badem S., Karan A., Ozdemir M., Okten R. S., Ozbulbul N. I., ...More

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, vol.26, no.11, pp.1622-1629, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 26 Issue: 11
Publication Date: 2015
Doi Number: 10.1016/j.jvir.2015.07.017
Journal Name: JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1622-1629
Lokman Hekim University Affiliated: No

Abstract

Purpose: To compare doxorubicin-loaded HepaSphere transarterial chemoembolization versus conventional transarterial chemoembolization in terms of survival, time to recurrence, acute reversible hepatotoxicity, postembolization syndrome, and chemoembolization-related mortality and morbidity.